Mount Sinai Recanati/Miller Transplantation Institute HBV & HCV Clinical Trials

“The Mount Sinai Recanati/Miller Transplantation Institute is currently participating in several Hepatitis B and Hepatitis C clinical trials.  For more information about these clinical research opportunities, you may contact the Clinical Research Director by phone at 212-241-0255 or email at TXresearch@mountsinai.org

More Research Board Posts

Paid Study | Hep C Online Communities

July 21, 2015

The Henne Group is conducting regarding Hepatitis C research by creating an online community which will be exploring the experiences of people living with Hep C. This is a paid study and completely confidential. We are contacting you to ask your help in inviting people to be part of a special online community for people who have … Continue reading Paid Study | Hep C Online Communities

read more »

2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters

June 17, 2015

    Abstracts, Presentations, and Posters are now Available Online Abstracts, presentations, and posters from the 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care are available on the Summit webpage. Final Program and Abstract Book (PDF) Program Overview and Plenary Presentations Breakout Session Presentations Posters More information on the 2015 National Summit is available at http://www.hivforum.org/2015Summit … Continue reading 2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters

read more »

Article| Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013

June 6, 2015

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend. 2015.  HCV prevalence among PWID (N:1535) was 67% during the study period, and was not significantly different from that observed in 2000-2001. The estimated HCV incidence among new injectors (persons injecting for ≤6 years) … Continue reading Article| Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013

read more »

Article| A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support.

Beyond Viral Response: a prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support.  International Journal of Drug Policy, 2015.  Highlights We prospectively study a community-based hepatitis C (HCV) treatment program serving active drug users in Toronto, Canada. We examine HCV care outcomes and changes in psycho-social status, including social determinants of health … Continue reading Article| A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support.

read more »

EncephalApp | Smartphone app to identify hepatic encephalopathy in 5 mins

Up to 50% of cirrhosis patients are at risk for — or may already have — covert hepatic encephalopathy, whose symptoms are particularly hard to diagnose using a routine physical examination. In a researcher blog from DDW, Jasmohan S. Bajaj, MBBS, MD, MS, offers insight into his new smartphone application that can quickly identify patients … Continue reading EncephalApp | Smartphone app to identify hepatic encephalopathy in 5 mins

read more »

Article | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs

June 5, 2015

An international perspective on using opioid substitution treatment (OST) to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential. International Journal of Drug Policy, 2015.  Highlights  We examined the use of mediation assisted treatment of opioid dependence to improve the HCV control. The stigmatization of drug use is … Continue reading Article | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs

read more »